Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Gilenya (fingolimod)
pCPA File Number:
20787
Negotiation Status:
Concluded with an LOI
Indication(s):
Multiple Sclerosis
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CADTH Project Number:
S0228
pCPA Engagement Letter Issued:
2012-07-01
Negotiation Process Concluded:
2013-03-04